<?xml version="1.0"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v3.0 20080202//EN" "archivearticle3.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?DTDIdentifier.IdentifierValue -//NLM//DTD Journal Publishing DTD v2.3 20070202//EN?>
  <?DTDIdentifier.IdentifierType public?>
  <?SourceDTD.DTDName journalpublishing.dtd?>
  <?SourceDTD.Version 2.3?>
  <?ConverterInfo.XSLTName jp2nlmx2.xsl?>
  <?ConverterInfo.Version 2?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Integr Med Insights</journal-id>
      <journal-title-group>
        <journal-title>Integrative Medicine Insights</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1177-3936</issn>
      <publisher>
        <publisher-name>Libertas Academica</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmc">3095195</article-id>
      <article-id pub-id-type="pmid">21614163</article-id>
      <article-id pub-id-type="doi">10.4137/IMI.S5782</article-id>
      <article-id pub-id-type="publisher-id">imi-2011-007</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>A Preliminary Study of the Effectiveness of Chinese Therapeutic Food on Regulating Female Reproductive Hormones</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Fu</surname>
            <given-names>Lulu</given-names>
          </name>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Xu</surname>
            <given-names>Hong</given-names>
          </name>
          <xref ref-type="corresp" rid="c1-imi-2010-007"/>
        </contrib>
        <aff id="af1-imi-2010-007">School of Biomedical and Health Sciences, Victoria University, PO Box 14428, Melbourne, Vic 8001, Australia</aff>
      </contrib-group>
      <author-notes>
        <corresp id="c1-imi-2010-007">Corresponding author email: <email>hong.xu@vu.edu.au</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2011</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>24</day>
        <month>3</month>
        <year>2011</year>
      </pub-date>
      <volume>6</volume>
      <fpage>7</fpage>
      <lpage>12</lpage>
      <permissions>
        <copyright-statement>&#xA9; the author(s), publisher and licensee Libertas Academica Ltd.</copyright-statement>
        <copyright-year>2010</copyright-year>
        <license>
          <license-p>This is an open access article. Unrestricted non-commercial use is permitted provided the original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>This study investigated the effectiveness of Chinese therapeutic food on female reproductive hormones in a double-blind, placebo-controlled clinical trial. Chinese kiwi fruit extract (Hong En No. 1) was provided for Australian peri-menopausal women for one month. Chinese medical assessment and urinary 2-hydroxyestrone (2-OHE) and 16alpha-hydroxyestrone (16alpha-OHE) tests were conducted. Twenty-six urinary samples (pre and post-trial) which met the requirement of testing were analysed, the ratio 2-OHE:16alpha-OHE of pre-trial (1.18 &#xB1; 0.34) and post-trial (0.97 &#xB1; 0.29) in the control group (n = 6) decreased but showed no significant change, this ratio of pre-trial (1.44 &#xB1; 0.16) and post-trial (1.65 &#xB1; 0.21) in the treatment group (n = 7) indicated an improvement (<italic>P</italic> = 0.066), which results in beneficial hormone regulation. The Chinese medicine assessment indicated that the patterns of disharmony mainly include <italic>Liver Qi stagnation</italic> and <italic>Liver</italic>-<italic>Kidney Yin deficiency</italic> patterns. No significant change observed in the control group, significant score reduction of the patterns of disharmony was achieved at post-trial in the treatment group, which indicates an improvement of general health condition.</p>
      </abstract>
      <kwd-group>
        <kwd>Chinese therapeutic food</kwd>
        <kwd>Chinese kiwi fruit</kwd>
        <kwd>reproductive hormones</kwd>
        <kwd>2-hydroxyestrone:16&#x3B1;-hydroxyestrone</kwd>
        <kwd>Chinese medicine patterns of disharmony</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title>Background</title>
      <p>Hormonal fluctuations are known to affect the quality of life at different stages in the human lifespan. In middle-aged peri-menopausal women, hormonal fluctuations are specifically known to impact both mental and physical health. Sometimes the health outcomes eventuate in severe diseases for many women, eg, breast cancer, coronary heart disease and osteoporosis.</p>
      <p>Treatments for hormonally-related diseases are available from both Western and Chinese perspectives. While there is a great deal of commonly shared ground between Western and Chinese medicine, the main difference between them is that diagnosis in Chinese medicine relies on patterns of disharmony or dysfunction of the organ systems and then aims to match the pattern of disharmony to observable pathophysiological change rather than explaining causes based solely in terms of pathophysiological malfunction.</p>
      <p>This study investigated the Chinese medicine patterns presented in this peri-menopausal group and the effectiveness of the selected Chinese food&#x2014;Chinese kiwi fruit extract on the regulation of the biomarker 2-hydroxyestrone:16&#x3B1;-hydroxyestrone. The outcomes were compared with a similar study conducted previously.</p>
    </sec>
    <sec>
      <title>Chinese Medicine Patterns of Disharmony</title>
      <p>In Chinese medicine, female hormonal related diseases are related to the <italic>Liver</italic> meridian. In menstrual disorders, <italic>Liver</italic> meridian and <italic>Kidney</italic> meridian functions are important factors.<xref ref-type="bibr" rid="b1-imi-2010-007">1</xref> During the fourteenth century, Dr Dan-Xi Zhu summarised that a woman, who was worried and depressed, would suffer from an accumulation of stagnation. The stagnation would be the cause of <italic>Spleen Qi</italic> deficiency, the <italic>Liver Qi</italic> rebels horizontally and the stagnation finally turns into nodules.<xref ref-type="bibr" rid="b1-imi-2010-007">1</xref> The selected Chinese food extract, can nourish <italic>yin</italic> and clear <italic>heat</italic> which may resolve the symptoms mentioned above (which prevent an unwanted change in hormonal levels) and improve the quality of women&#x2019;s lives.<xref ref-type="bibr" rid="b2-imi-2010-007">2</xref>,<xref ref-type="bibr" rid="b3-imi-2010-007">3</xref></p>
      <p>Comparisons between modern diagnostic methods (eg, bio-marker tests) and Chinese medicine diagnostic methods indicate that <italic>Liver Qi</italic> stagnation and <italic>Liver-Kidney Yin</italic> deficiency may be the two main patterns of pre-clinical changes in the breast.<xref ref-type="bibr" rid="b4-imi-2010-007">4</xref></p>
    </sec>
    <sec>
      <title>Female Reproductive Hormones</title>
      <p>Female reproductive hormones have an important role in hormonally related breast cancer growth.<xref ref-type="bibr" rid="b5-imi-2010-007">5</xref> Endocrine therapy has been developed based on the hormone and cancer relationship, for example the oestrogen receptor blocker, tamoxifen, has been widely used.<xref ref-type="bibr" rid="b6-imi-2010-007">6</xref> Breast cancer oestrogen receptor (ER) status is useful in predicting benefits from endocrine therapy.<xref ref-type="bibr" rid="b7-imi-2010-007">7</xref></p>
      <p>In spite of the benefit of oestrogen receptor blockers for breast cancer treatment, modern research has investigated oestrogen specific pathways, which are involved in oestrogen metabolism and play a role in the aetiology of breast cancer.<xref ref-type="bibr" rid="b8-imi-2010-007">8</xref> A large population based case control study has been used to assess the association of the urinary oestrogen metabolites 2-hydroxyestrone (2-OHE) and 16&#x3B1;-hydroxyestrone (16&#x3B1;-OHE) and their ratio in breast cancer.<xref ref-type="bibr" rid="b9-imi-2010-007">9</xref> The mean of 2-OHE:16&#x3B1;-OHE ratio is reported at 1.6:1 in 42 postmenopausal patients and in the breast cancer patient is reported at 0.71:1.<xref ref-type="bibr" rid="b10-imi-2010-007">10</xref> Studies indicate 2-OHE is a weak acting oestrogen, non-genotoxic and has an antiestrogen effect.<xref ref-type="bibr" rid="b11-imi-2010-007">11</xref>,<xref ref-type="bibr" rid="b12-imi-2010-007">12</xref> In Lewis&#x2019; research,<xref ref-type="bibr" rid="b13-imi-2010-007">13</xref> 16&#x3B1;-OHE has been found as a potent oestrogen which is capable of accelerating cell cycle kinetics and stimulating the expression of cell cycle regulatory proteins. Lewis also stated that 16&#x3B1;-OHE is a potent stimulator of DNA synthesis in ER-positive breast cancer cells.<xref ref-type="bibr" rid="b13-imi-2010-007">13</xref></p>
      <p>In view of the above, a high level of 16&#x3B1;-OHE will stimulate the ER-positive breast cancer growth and a high ratio of 2-OHE:16&#x3B1;-OHE may be of benefit to reduce breast cancer incidence. The ratio of 2-OHE:16&#x3B1;-OHE has also been used as a biomarker for breast cancer in clinical trials.<xref ref-type="bibr" rid="b14-imi-2010-007">14</xref>,<xref ref-type="bibr" rid="b15-imi-2010-007">15</xref></p>
    </sec>
    <sec>
      <title>Chinese Kiwi Fruit Extract</title>
      <p>Chinese herbal formulae and food therapy have long been used to effectively regulate endocrinal disorders in Chinese clinical practice.<xref ref-type="bibr" rid="b1-imi-2010-007">1</xref>,<xref ref-type="bibr" rid="b2-imi-2010-007">2</xref> One Chinese food therapy of interest is the Chinese food extract&#x2014;Chinese kiwi fruit drink, Kiwi fruit (Actinidia chinensis) is rich in vitamin C, vitamin E, vitamin K, folate, antithetic acid, niacin, lutein, zeaxanthin, arytenoids, falconoid, calcium, iron, manganese, selenium, zinc, copper, potassium and magnesium, fibre and amino acids.<xref ref-type="bibr" rid="b16-imi-2010-007">16</xref>,<xref ref-type="bibr" rid="b17-imi-2010-007">17</xref> The selected extract contains polysaccharides, multiple kinds of organic acids, isoflavones and adequate amounts of trace elements, all of which have been previously used to increase the bio-marker 2-OHE:16&#x3B1;-OHE.<xref ref-type="bibr" rid="b2-imi-2010-007">2</xref>,<xref ref-type="bibr" rid="b18-imi-2010-007">18</xref> This extract is used to improve the quality of life of women suffering from endocrine disorders.<xref ref-type="bibr" rid="b19-imi-2010-007">19</xref> Research indicates that Kiwi fruit itself may be a potential therapeutic product for preventing cancer.<xref ref-type="bibr" rid="b16-imi-2010-007">16</xref>,<xref ref-type="bibr" rid="b20-imi-2010-007">20</xref>&#x2013;<xref ref-type="bibr" rid="b22-imi-2010-007">22</xref></p>
      <p>The Chinese kiwi fruit extract contains isoflavones which are categorised as phytoestrogens. Their functions are different to oestrogen<xref ref-type="bibr" rid="b22-imi-2010-007">22</xref> and the isoflavones will not cause side effects like those commonly attributed to hormone replacement therapy. A cohort study found that the therapy, which combined oestrogen with progestin, was associated with an increased risk of breast cancer, stroke, venous thromboembolic disease and heart disease.<xref ref-type="bibr" rid="b23-imi-2010-007">23</xref> Isoflavone can increase the ratio of 2-OHE:16&#x3B1;-OHE and reduce the risk of breast cancer.<xref ref-type="bibr" rid="b12-imi-2010-007">12</xref></p>
      <p>The Chinese kiwi fruit extract was investigated in a series of laboratory, animal and human studies and found to have anti-mutagenic, anti-carcinogenic, anti-oxidant, anti-atherogenic and anti-toxicity effects, as well as assisting in DNA repair and stimulating the immune system.<xref ref-type="bibr" rid="b24-imi-2010-007">24</xref></p>
    </sec>
    <sec sec-type="methods">
      <title>Methods</title>
      <p>Fourteen middle aged women responded to newspaper advertisements and were recruited as participants of this study at Victoria University according to the following criteria: female, Melbourne resident; aged from 40 to 55 (not experiencing amenorrhoea over two years). Criteria for applicant exclusion:
<list list-type="bullet"><list-item><p>Pregnant or breast feeding</p></list-item><list-item><p>Positive mammogram or ultrasound diagnosis of breast cancer</p></list-item><list-item><p>Undertaking hormone therapy or taking any form of contraceptive pills</p></list-item><list-item><p>Taking tamoxifen or undergoing chemotherapy after surgical treatment of breast cancer</p></list-item><list-item><p>Suffering from liver and/or kidney disease</p></list-item><list-item><p>Being post-menopausal or experiencing amenorrhoea over two years</p></list-item><list-item><p>Food allergy or history of intolerance to kiwi fruit</p></list-item><list-item><p>Suffering from a major chronic disorder which required of taking medications</p></list-item></list></p>
      <p>The selected Chinese therapeutic food is a wild resourced Chinese kiwi fruit extract (Hong En No. 1, also known as Hong En Health Drink) in powder form, provided by Professor Houen Xu of Peking University. This extract meets the requirement of providing therapeutic efficient 3-OH isoflavones, extracted by ethanol-water extraction method.</p>
      <p>In this double-blind, placebo-controlled clinical trial, the participants were randomly assigned into treatment (taking the Chinese kiwi fruit extract) and control group (taking placebo) using numbered order as they became available. The group assignments were kept blind from the participants and data collectors.</p>
      <p>Participants in treatment group took 10 g powder each time, twice a day, mixed with 100 ml warm water.<xref ref-type="bibr" rid="b24-imi-2010-007">24</xref> The selected dosage was recommended by a number of Chinese medicine practitioners and laboratory experiments.<xref ref-type="bibr" rid="b3-imi-2010-007">3</xref>,<xref ref-type="bibr" rid="b19-imi-2010-007">19</xref> The powder was administered one hour before meals (breakfast and dinner), over a one month period.</p>
      <p>Chinese medicine assessment involved standard Chinese medicine diagnostic procedures<xref ref-type="bibr" rid="b25-imi-2010-007">25</xref> which include questioning of symptoms, checking of pulse and observing the tongue of the participants by two registered Chinese medicine practitioners. The symptoms and signs in relation to <italic>Liver Qi Stagnation</italic> including: anger, stress, abdominal bloating, excessive dreams, irregular menstruation, bitter taste in mouth and wiry pulse; The symptoms and signs in relation to <italic>Liver-Kidney Yin</italic> deficiency including: lower back pain, weak knee, hot flushes, tinnitus, night sweating, scanty menstruation, dry throat, red tongue, less tongue coating, thin and rapid pulse. The collected symptoms and signs were matched to patterns of disharmony, using the 0&#x2013;10 scale (agreeable by the practitioners). The scores represent the levels of disharmony from 0 to a maximum of 10. Scores between 1&#x2013;5 are recognised as minor patterns of disharmony, while those between 6&#x2013;10 are severe patterns of disharmony.</p>
      <p>2-OHE:16&#x3B1;-OHE urine test used the ESTRAMET Urinary Estrogen Metabolite Kit (from IMMUNA CARE Corporation), which is a competitive, solid-phase enzyme immunoassays.<xref ref-type="bibr" rid="b18-imi-2010-007">18</xref> The collected urine samples at the pre and post-trial were analysed. Procedures follow the requirement of the Urinary Estrogen Metabolite Kit. Urinary oestrogen is ordinarily measured normalized according to urinary creatinine concentration in units of nanograms, which is the ratio of oestrogen to per mg creatinine. The correlation of ESTRAMET 2-OHE and 16&#x3B1;-OHE versus these metabolites by Gas Chromatography-Mass Spectroscopy (GCMS) method were greater than 0.94.<xref ref-type="bibr" rid="b26-imi-2010-007">26</xref> Data were analysed using <italic>t-test</italic> by SPSS 18.</p>
      <p>The study was approved by the relative committee and the ethics approval was gained from the Human Research Ethics Committee of Victoria University, Australia. All participants received an explanation document and a consent form for completion.</p>
    </sec>
    <sec sec-type="results|discussion">
      <title>Results and Discussion</title>
      <p>Thirteen participants completed all the tests, one withdrew due to other health condition. Twenty-six urinary samples (pre and post-trial) which met the requirement of testing were analysed, the ratio 2-OHE:16&#x3B1;-OHE of pre-trial (1.18 &#xB1; 0.34) and post-trial (0.97 &#xB1; 0.29) in the control group (n = 6) decreased but showed no significant change, this ratio of pre-trial (1.44 &#xB1; 0.16) and post-trial (1.65 &#xB1; 0.21) in the treatment group (n = 7) indicated an improvement (<italic>P</italic> = 0.066), which results in beneficial hormone regulation (See <xref ref-type="table" rid="t1-imi-2010-007">Table 1</xref>). The Chinese medicine assessment indicated that the patterns of disharmony mainly include <italic>Liver Qi stagnation</italic> and <italic>Liver</italic>-<italic>Kidney Yin deficiency</italic> patterns. Significant score reduction of the patterns of disharmony was achieved at post-trial in the treatment group, no significant change observed in the control group (See <xref ref-type="table" rid="t2-imi-2010-007">Table 2</xref>).</p>
      <p>Chinese medicine assessment indicated that the participants felt correspondingly weaker and their health conditions also had adverse trends in their middle age. They commonly had mood swings which relates to <italic>Liver Qi</italic> stagnation.<xref ref-type="bibr" rid="b1-imi-2010-007">1</xref> Peri-menopausal symptoms also affected their daily life. Data collected from these participants at this stage of testing indicated that the adverse symptoms and relative signs changed after the treatment resulting in the levels of disharmony being reduced.</p>
      <p>The results of this study have further approved a similar conclusion to a previous pilot study, with six Chinese menopausal women, who were administered 100 ml Hong En No. 1 drink for two days. Their urine sample ratio of 2-OHE:16&#x3B1;-OHE was elevated by the intake of this drink.<xref ref-type="bibr" rid="b24-imi-2010-007">24</xref> After a two day period of usage, 16&#x3B1;-OHE had reduced significantly that benefit women&#x2019;s health.</p>
      <p>In a previous clinical trial,<xref ref-type="bibr" rid="b3-imi-2010-007">3</xref> thirty-nine participants, who were diagnosed with cancer and had just completed chemotherapy, were given this drink (equal to 20 g of Hong En No. 1) daily over a seven day period. The results indicated the rate of binucleate lymphocyte cells with micronuclei in these participants had significantly decreased. This may indicate the recovery of chromosome change.<xref ref-type="bibr" rid="b3-imi-2010-007">3</xref></p>
      <p>According to Bradlow<xref ref-type="bibr" rid="b18-imi-2010-007">18</xref> the urine 2-OHE:16&#x3B1;-OHE ratio is stable over the menstrual cycle of women who have not taken oral contraceptives. The results gained from these studies demonstrate a reliable outcome which using 2-OHE:16&#x3B1;-OHE as a biomarker to evaluate the effectiveness of the selected Chinese therapeutic food on reproductive hormone. These results indicated that Chinese kiwi fruit extract can benefit the reproductive hormones for middle aged women, therefore reduce the risk of hormone fluctuation related diseases.</p>
      <p>After the completion of the trial, it was shown that the changes of patterns of disharmony indicated in the Chinese medicine assessment are relevant to the change of biomedical markers, which may be useful in western-medical assessment of hormones fluctuation and pre-clinical breast diseases. If Chinese medicine diagnostic methods indicate that <italic>Liver Qi</italic> stagnation and <italic>Liver-Kidney Yin</italic> deficiency are the main patterns of middle aged women hormone fluctuation or pre-clinical breast diseases, it is reasonable to argue that the treatment principle should be based on regulating <italic>Qi</italic> and nourishing <italic>Yin</italic>. This study has provided a repeatable evidence of using the Chinese kiwi fruit extract for the regulation of hormonal disorder and Chinese medicine patterns of disharmony.</p>
    </sec>
    <sec sec-type="conclusions">
      <title>Conclusions</title>
      <p>In this study, the patterns of disharmony for a group of middle aged Australian women presented reflect the Chinese medicine theory that <italic>Liver Qi</italic> stagnation and <italic>Liver-Kidney Yin deficiency</italic> are the main patterns for this group. The bio markers used in this study are both reliable and sensitive in order to investigate the hormone imbalance. The selection of the Chinese therapeutic food&#x2014;Chinese kiwi fruit extract could benefit those concerned with peri-menopausal symptoms or diseases associated with hormone disorders and treat the patterns of disharmony.</p>
    </sec>
  </body>
  <back>
    <ack>
      <p>We would to thank Associate Professor Jack Antonas of Victoria University who has assisted in proposing the study. We would also like to thank the participants for their involvement in this research.</p>
    </ack>
    <fn-group>
      <fn>
        <p>
          <bold>Disclosures</bold>
        </p>
        <p>This manuscript has been read and approved by all authors. This paper is unique and not under consideration by any other publication and has not been published elsewhere. The authors and peer reviewers report no conflicts of interest. The authors confirm that they have permission to reproduce any copyrighted material.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-imi-2010-007">
        <label>1.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Niu</surname>
              <given-names>JZ</given-names>
            </name>
          </person-group>
          <source>Modern Gynecology of Traditional Chinese and Western Medicine</source>
          <publisher-loc>Beijing</publisher-loc>
          <publisher-name>China Science and Technology Publishing House</publisher-name>
          <year>1996</year>
          <fpage>39</fpage>
          <lpage>46</lpage>
        </element-citation>
      </ref>
      <ref id="b2-imi-2010-007">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Xu</surname>
              <given-names>HE</given-names>
            </name>
          </person-group>
          <article-title>Chinese food and cancer healing</article-title>
          <source>Integr Med Insights</source>
          <year>2006</year>
          <volume>1</volume>
          <fpage>1</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="b3-imi-2010-007">
        <label>3.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>HE</given-names>
            </name>
          </person-group>
          <source>Hong-En Health Drink&#x2014;Development and Research</source>
          <publisher-loc>Beijing</publisher-loc>
          <publisher-name>Beijing Medical University Publishing House</publisher-name>
          <year>1999</year>
          <fpage>11</fpage>
          <lpage>21</lpage>
        </element-citation>
      </ref>
      <ref id="b4-imi-2010-007">
        <label>4.</label>
        <element-citation publication-type="confproc">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The use of Chinese herbs and food in preventing breast cancer</article-title>
          <conf-name>AACMA National Annual Conference: 19&#x2013;21 May 2006</conf-name>
          <comment>Adelaide. Edited by AACMA</comment>
          <year>2006</year>
          <fpage>26</fpage>
        </element-citation>
      </ref>
      <ref id="b5-imi-2010-007">
        <label>5.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Toma</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Emionite</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Scaramuccia</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Ravera</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Scarabelli</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Retinoids and human breast cancer: in vivo effects of an antagonist for PAR-alpha</article-title>
          <source>Cancer Lett</source>
          <year>2005</year>
          <volume>219</volume>
          <fpage>27</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">15694661</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-imi-2010-007">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Higgins</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Adjuvant endocrine therapy for premenopausal hormone receptor-postive breast cancer: much done, more to do</article-title>
          <source>Oncology</source>
          <year>2009</year>
          <volume>23</volume>
          <fpage>1</fpage>
        </element-citation>
      </ref>
      <ref id="b7-imi-2010-007">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berry</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Cirrincione</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Henderson</surname>
              <given-names>C</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Oestrogen-receptor status and outcomes of modern chemotherapy for patients with node-positive breast cancer</article-title>
          <source>JAMA</source>
          <year>2006</year>
          <volume>295</volume>
          <fpage>1658</fpage>
          <lpage>67</lpage>
          <pub-id pub-id-type="pmid">16609087</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-imi-2010-007">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bentz</surname>
              <given-names>AT</given-names>
            </name>
            <name>
              <surname>Schneider</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Westerlind</surname>
              <given-names>KC</given-names>
            </name>
          </person-group>
          <article-title>The relationship between physical activity and 2-hydroxyestrone, 16&#x3B1;-hydroxyestrone, and the 2/16 ratio in premenopausal women</article-title>
          <source>Cancer Cause Control</source>
          <year>2005</year>
          <volume>16</volume>
          <fpage>455</fpage>
          <lpage>61</lpage>
        </element-citation>
      </ref>
      <ref id="b9-imi-2010-007">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kabat</surname>
              <given-names>GC</given-names>
            </name>
            <name>
              <surname>O&#x2019;Leary</surname>
              <given-names>ES</given-names>
            </name>
            <name>
              <surname>Gammon</surname>
              <given-names>MD</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Oestrogen metabolism and breast cancer</article-title>
          <source>Epidemiology</source>
          <year>2006</year>
          <volume>17</volume>
          <fpage>80</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="pmid">16357599</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-imi-2010-007">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meilahn</surname>
              <given-names>EN</given-names>
            </name>
            <name>
              <surname>De Stavola</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Allen</surname>
              <given-names>DS</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Do urinary oestrogen metabolites predict cancer? The Guernsey III cohort follow-up</article-title>
          <source>Brit J Cancer</source>
          <year>1998</year>
          <volume>78</volume>
          <fpage>1250</fpage>
          <lpage>5</lpage>
          <pub-id pub-id-type="pmid">9820189</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-imi-2010-007">
        <label>11.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schneider</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Huh</surname>
              <given-names>MM</given-names>
            </name>
            <name>
              <surname>Bradlow</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Fishman</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Antiestrogen action of 2-hydroxyestrone on MCF-7 human breast cancer cells</article-title>
          <source>J Biochem</source>
          <year>1984</year>
          <volume>259</volume>
          <fpage>4840</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="b12-imi-2010-007">
        <label>12.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kishida</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Beppu</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Nashiki</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Izumi</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Ebihara</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Effect of dietary soy isoflavone aglycones on the urinary 16alpha to 2-Hydroxyestrone ratio in C3H/Hej mice</article-title>
          <source>Nutr Cancer</source>
          <year>2000</year>
          <volume>38</volume>
          <fpage>209</fpage>
          <lpage>14</lpage>
          <pub-id pub-id-type="pmid">11525599</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-imi-2010-007">
        <label>13.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lewis</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>TJ</given-names>
            </name>
            <name>
              <surname>Klinge</surname>
              <given-names>CM</given-names>
            </name>
            <name>
              <surname>Gallo</surname>
              <given-names>MA</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Regulation of cell cycle and cyclins by 16 alpha hydroxyestrone in MCF-7 breast cancer cells</article-title>
          <source>J Mol Endocrinol</source>
          <year>2001</year>
          <volume>27</volume>
          <fpage>293</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="pmid">11719282</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-imi-2010-007">
        <label>14.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lukaczer</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Darland</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Tripp</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical effects of a proprietary combination isoflavone nutritional supplement in menopausal women: a pilot trial</article-title>
          <source>Altern Ther Health M</source>
          <year>2005</year>
          <volume>11</volume>
          <fpage>60</fpage>
          <lpage>5</lpage>
        </element-citation>
      </ref>
      <ref id="b15-imi-2010-007">
        <label>15.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lu</surname>
              <given-names>LJW</given-names>
            </name>
            <name>
              <surname>Gree</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Josyula</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Nagamani</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Grady</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Anderson</surname>
              <given-names>KE</given-names>
            </name>
          </person-group>
          <article-title>Increased urinary excretion of 2- hydroxyestrone but not 16&#x3B1;-hydroxyestrone in premenopausal women during a soya diet containing isoflavones</article-title>
          <source>Cancer Res</source>
          <year>2000</year>
          <volume>60</volume>
          <fpage>1299</fpage>
          <lpage>305</lpage>
          <pub-id pub-id-type="pmid">10728690</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-imi-2010-007">
        <label>16.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collins</surname>
              <given-names>BH</given-names>
            </name>
            <name>
              <surname>Horsk&#xE1;</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Hotten</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Riddoch</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Collins</surname>
              <given-names>AR</given-names>
            </name>
          </person-group>
          <article-title>A kiwifruit protects against oxidative DNA damage in human cells and in vitro</article-title>
          <source>Nutr Cancer</source>
          <year>2001</year>
          <volume>39</volume>
          <fpage>148</fpage>
          <lpage>53</lpage>
          <pub-id pub-id-type="pmid">11588897</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-imi-2010-007">
        <label>17.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yong</surname>
              <given-names>LC</given-names>
            </name>
            <name>
              <surname>Brown</surname>
              <given-names>CC</given-names>
            </name>
            <name>
              <surname>Schatzkin</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Intakes of Vitamin E, C, A and risk of Lung cancer. The NHANES 1 epidemiologic follow-up study. First National Health and Nutrition Examination Survey</article-title>
          <source>Am J Epidemiol</source>
          <year>1997</year>
          <volume>146</volume>
          <fpage>231</fpage>
          <lpage>43</lpage>
          <pub-id pub-id-type="pmid">9247007</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-imi-2010-007">
        <label>18.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bradlow</surname>
              <given-names>HL</given-names>
            </name>
            <name>
              <surname>Jernstr&#xF6;m</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Sepkovic</surname>
              <given-names>DW</given-names>
            </name>
            <name>
              <surname>Klug</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Narod</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Comparison of plasma and urinary levels of 2-hydroxyestrogen and 16&#x3B1;-hydroxyestrogen metabolites</article-title>
          <source>Mol Genet Metab</source>
          <year>2006</year>
          <volume>87</volume>
          <fpage>135</fpage>
          <lpage>46</lpage>
          <pub-id pub-id-type="pmid">16165383</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-imi-2010-007">
        <label>19.</label>
        <element-citation publication-type="other">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Effects of Exercise and Traditional Chinese Medicine Modalities on Bone Structure and Function</article-title>
          <comment><italic>PhD thesis.</italic> Victoria University, Faculty of Human Development;</comment>
          <year>2002</year>
          <fpage>17</fpage>
          <lpage>27</lpage>
          <fpage>214</fpage>
          <lpage>236</lpage>
        </element-citation>
      </ref>
      <ref id="b20-imi-2010-007">
        <label>20.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nebe</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Peters</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Duske</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Richter</surname>
              <given-names>DU</given-names>
            </name>
            <name>
              <surname>Briese</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Influence of phytoestrogen on the proliferation and expression of adhesion receptors in human mammary epithelial cells in vitro</article-title>
          <source>Eur J Cancer Prev</source>
          <year>2006</year>
          <volume>5</volume>
          <fpage>405</fpage>
          <lpage>15</lpage>
          <pub-id pub-id-type="pmid">16912569</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-imi-2010-007">
        <label>21.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Motohashi</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Shirataki</surname>
              <given-names>Y</given-names>
            </name>
            <name>
              <surname>Kawase</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Cancer prevention and therapy with kiwi fruit in Chinese folklore medicine: a study of kiwi fruit extracts</article-title>
          <source>J Ethnopharmacol</source>
          <year>2002</year>
          <volume>81</volume>
          <fpage>357</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">12127237</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-imi-2010-007">
        <label>22.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Horn-Ross</surname>
              <given-names>PL</given-names>
            </name>
            <name>
              <surname>John</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>M</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Phytoestrogen consumption and breast cancer risk in a multiethnic population</article-title>
          <source>Am J Epidemiol</source>
          <year>2001</year>
          <volume>154</volume>
          <fpage>434</fpage>
          <lpage>41</lpage>
          <pub-id pub-id-type="pmid">11532785</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-imi-2010-007">
        <label>23.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <collab>Writing Group for the Women&#x2019;s Health Initiative Investigators</collab>
          </person-group>
          <article-title>Risks and benefits of oestrogen plus progestin in healthy postmenopausal women: principal results from the women&#x2019;s health initiative randomized controlled trial</article-title>
          <source>JAMA</source>
          <year>2002</year>
          <volume>288</volume>
          <fpage>321</fpage>
          <lpage>33</lpage>
          <pub-id pub-id-type="pmid">12117397</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-imi-2010-007">
        <label>24.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Xu</surname>
              <given-names>HE</given-names>
            </name>
          </person-group>
          <article-title>Chinese kiwi fruit and health</article-title>
          <source>The Progress of Resource, Environment and Health in China</source>
          <comment>SCOPE China Publication Series III. Chief Edited by Xu HE</comment>
          <publisher-loc>Beijing</publisher-loc>
          <publisher-name>Peking University Medical Press</publisher-name>
          <year>2004</year>
          <fpage>113</fpage>
          <lpage>33</lpage>
        </element-citation>
      </ref>
      <ref id="b25-imi-2010-007">
        <label>25.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Deng</surname>
              <given-names>TT</given-names>
            </name>
          </person-group>
          <source>Traditional Chinese Medicine Diagnosis</source>
          <publisher-loc>Beijing</publisher-loc>
          <publisher-name>People&#x2019;s Health Publishing House</publisher-name>
          <year>1997</year>
          <fpage>26</fpage>
          <lpage>268</lpage>
        </element-citation>
      </ref>
      <ref id="b26-imi-2010-007">
        <label>26.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klug</surname>
              <given-names>TL</given-names>
            </name>
            <name>
              <surname>Bradlow</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Monoclonal antiboey-based enzyme immunoassay for simultaneous queatitation of 2- and 16 alpha-hydroxyestrone in urine</article-title>
          <source>Steroids</source>
          <year>1994</year>
          <volume>59</volume>
          <fpage>648</fpage>
          <lpage>55</lpage>
          <pub-id pub-id-type="pmid">7701541</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <table-wrap id="t1-imi-2010-007" position="float">
      <label>Table 1</label>
      <caption>
        <p>The effects of Chinese kiwi fruit extract on urinary 2OHE:16&#x3B1;-OHE of peri-menopausal women.<xref ref-type="table-fn" rid="tfn2-imi-2010-007">*</xref></p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Groups</bold>
            </th>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Age</bold>
            </th>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Pre-trial 2OHE:16&#x3B1;-OHE</bold>
            </th>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Post-trial 2OHE:16&#x3B1;-OHE</bold>
            </th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Treatment (n = 7)</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">47.71 &#xB1; 4.68</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">1.44 &#xB1; 0.16</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">1.65 &#xB1; 0.21<xref ref-type="table-fn" rid="tfn3-imi-2010-007">**</xref></td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Control (n = 6)</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">48.33 &#xB1; 6.71</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">1.18 &#xB1; 0.34</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">0.97 &#xB1; 0.29</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn1-imi-2010-007">
          <p>
            <bold>Notes:</bold>
          </p>
        </fn>
        <fn id="tfn2-imi-2010-007">
          <label>*</label>
          <p>Participants take Chinese kiwi fruit extract (Hong En No. 1) 10 g &#xD7; 2/days &#xD7; 4weeks;</p>
        </fn>
        <fn id="tfn3-imi-2010-007">
          <label>**</label>
          <p><italic>P</italic> = 0.066, t = 2.244.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t2-imi-2010-007" position="float">
      <label>Table 2</label>
      <caption>
        <p>Levels of <italic>Liver Qi stagnation</italic> and <italic>Liver-Kidney Yin deficiency</italic> at pre and post-trial.</p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th align="left" valign="top" rowspan="2" colspan="1">
              <bold>Groups</bold>
            </th>
            <th colspan="2" align="left" valign="top" rowspan="1">
              <bold>
                <italic>Liver Qi stagnation</italic>
              </bold>
              <hr/>
            </th>
            <th colspan="2" align="left" valign="top" rowspan="1">
              <bold>
                <italic>Liver-Kidney Yin deficiency</italic>
              </bold>
              <hr/>
            </th>
          </tr>
          <tr>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Pre-trial score (0&#x2013;10)</bold>
            </th>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Post-trial score (0&#x2013;10)</bold>
            </th>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Pre-trial score (0&#x2013;10)</bold>
            </th>
            <th align="left" valign="top" rowspan="1" colspan="1">
              <bold>Post-trial score (0&#x2013;10)</bold>
            </th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Treatment (n = 7)</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">7.43 &#xB1; 1.27</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">2.29 &#xB1; 0.49<xref ref-type="table-fn" rid="tfn5-imi-2010-007">*</xref></td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">5.14 &#xB1; 1.77</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">2.43 &#xB1; 1.72<xref ref-type="table-fn" rid="tfn6-imi-2010-007">**</xref></td>
          </tr>
          <tr>
            <td align="left" valign="top" rowspan="1" colspan="1">Control (n = 6)</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">7.00 &#xB1; 1.10</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">7.20 &#xB1; 0.98</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">5.17 &#xB1; 1.94</td>
            <td align="left" valign="bottom" rowspan="1" colspan="1">5.17 &#xB1; 1.94</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn id="tfn4-imi-2010-007">
          <p>
            <bold>Notes:</bold>
          </p>
        </fn>
        <fn id="tfn5-imi-2010-007">
          <label>*</label>
          <p><italic>P</italic> = 0.00, t = 12.73;</p>
        </fn>
        <fn id="tfn6-imi-2010-007">
          <label>**</label>
          <p><italic>P</italic> = 0.00, t = 7.55.</p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
